Peripheral Neuropathy Trial, Recruiting (NCT03981276)

Peripheral Neuropathy Trial, Recruiting NCT03981276 Sponsor: Dr. Rebecca Schule Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT03981276 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with Hereditary Spastic Paraplegia (HSP) or a related condition, either through a doctor's assessment or a genetic test
Unaffected family members (a parent, child, sibling, aunt, uncle, or grandparent) of someone diagnosed with HSP or a related condition, who are able to give their own consent to take part
Healthy volunteers who are not related to anyone with HSP, who are able to give their own consent to take part
People who are willing and able to follow the study procedures as required
People who have provided written consent to participate

Who may not be able to join:

People who have not provided written informed consent, or where a legal representative has not provided consent on their behalf where required
Healthy volunteers who have signs of a neurodegenerative disease (a condition that causes the nervous system to break down over time) or a movement disorder
Healthy volunteers who are not able to give their own informed consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rebecca Schüle, PD Dr., University Hospital Tübingen

Phone: +49 7071 29

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03981276

Sponsor: Dr. Rebecca Schule

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: +49 7071 29

More information: https://clinicaltrials.gov/study/NCT03981276

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with Hereditary Spastic Paraplegia (HSP) or a related condition, either through a doctor's assessment or a genetic test
Unaffected family members (a parent, child, sibling, aunt, uncle, or grandparent) of someone diagnosed with HSP or a related condition, who are able to give their own consent to take part
Healthy volunteers who are not related to anyone with HSP, who are able to give their own consent to take part
People who are willing and able to follow the study procedures as required
People who have provided written consent to participate

Who may not be able to join:

People who have not provided written informed consent, or where a legal representative has not provided consent on their behalf where required
Healthy volunteers who have signs of a neurodegenerative disease (a condition that causes the nervous system to break down over time) or a movement disorder
Healthy volunteers who are not able to give their own informed consent

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Dr. Rebecca Schule

Registry

ClinicalTrials.gov

Start date

14 October 2019

Est. completion

1 August 2039

Where this trial is recruiting

🇦🇹 Austria 🇩🇪 Germany 🇮🇹 Italy

Primary endpoints

Change from baseline of Spastic Paraplegia Rating Scale (SPRS) total score at 2 years

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov